Direct RNA-based detection of CTX-M β-lactamases in human blood samples

International Journal of Medical Microbiology : IJMM
Claudia SteinMathias W Pletz

Abstract

Bloodstream infections with ESBL-producers are associated with increased mortality, which is due to delayed appropriate treatment resulting in clinical failure. Current routine diagnostics for detection of bloodstream infections consists of blood culture followed by species identification and susceptibility testing. In attempts to improve and accelerate diagnostic procedures, PCR-based methods have been developed. These methods focus on species identification covering only a limited number of ESBL coding genes. Therefore, they fail to cover the steadily further evolving genetic diversity of clinically relevant β-lactamases. We have recently designed a fast and novel RNA targeting method to detect and specify CTX-M alleles from bacterial cultures, based on an amplification-pyrosequencing approach. We further developed this assay towards a diagnostic tool for clinical use and evaluated its sensitivity and specificity when applied directly to human blood samples. An optimized protocol for mRNA isolation allows detection of specific CTX-M groups from as little as 100 CFU/mL blood via reverse transcription, amplification, and pyrosequencing directly from human EDTA blood samples as well as from pre-incubated human blood cultures wit...Continue Reading

References

Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Antonio OliverFred C Tenover
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Aug 11, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maja BabicRobert A Bonomo
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Mar 26, 2010·Intensive Care Medicine·Mathias W PletzTobias Welte
Dec 7, 2010·International Journal of Antimicrobial Agents·Michela PaolucciVittorio Sambri
Jul 19, 2011·Emerging Infectious Diseases·Ilse OverdevestJan Kluytmans
Oct 18, 2011·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
Nov 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R LeclercqG Kahlmeter
Mar 10, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Joshua T FreemanDavid J Holland
Apr 10, 2012·Frontiers in Microbiology·Rafael CantónJuan Carlos Galán
Apr 18, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R CantónUNKNOWN European Network on Carbapenemases
Jun 1, 2012·Critical Care : the Official Journal of the Critical Care Forum·Arash AfshariStephan Harbarth

❮ Previous
Next ❯

Citations

Jun 3, 2017·Der Internist·M W PletzT Welte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Babesiosis

Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.